Ophthalmologists play a vital role in educating both patients and prescribing physicians about the risk of toxicity associated with exposure to hydroxychloroquine (HCQ) and chloroquine (CQ) drugs. Because the damage from these drugs is irreversible, knowledge of proper dosages and familiarity with the signs of early stage retinopathy are critical for preventing central vision loss. Aao plaquenil 2016 guidelines Afraid to try plaquenil Aim To compare current hydroxychloroquine retinopathy screening practices with the published 2002 American Academy of Ophthalmology AAO Preferred Practice Patterns PPP. Methods A multiple-choice survey was distributed to 105 ophthalmologists to assess current screening practices and knowledge of patient risk factors. The American Academy of Ophthalmology recommendations for screening of chloroquine CQ and hydroxychloroquine HCQ retinopathy were published in 2002, but improved screening tools and new knowledge about the prevalence of toxicity have appeared in the ensuing years. AAO 2020 paper/poster and video abstracts are accepted March 12 - April 14, 2020. View. APR 22. Canceled Mid-Year Forum 2020 Renaissance Downtown, Washington, D. C. This annual forum provides an opportunity for Academy members, leaders and leaders of allied ophthalmic organizations to identify and discuss critical issues facing ophthalmology. The patient can be advised about the risk of further visual loss depending on the severity of the retinopathy. Summary of dosing guidelines Once definitive signs of retinopathy are recognized, the decision to stop medication should be made in conjunction with the patient and the prescribing physician to ensure that medical risks, such as a potential flare of systemic lupus erythematosus (SLE), are managed. Aao plaquenil ppp About Preferred Practice Patterns PPPs -, Revised Recommendations on Screening for Chloroquine and. Chloroquine treatment of berghei i.pDoctor took me off of plaquenil Jun 13, 2019 Plaquenil and your eyes. A rare side effect of Plaquenil is damage to the eye's retina. The retina is the light-sensitive tissue at the back of the eye. Using Plaquenil for a long period of time may harm the retina, causing serious vision loss. People with retinal damage from Plaquenil are not aware at first that they are losing vision. What Is Plaquenil? - American Academy of Ophthalmology. American Academy of Ophthalmology. Recommendations on Screening for Chloroquine and.. Apr 20, 2011 In 2002, the American Academy of Ophthalmology AAO established ocular examination guidelines for screening patients on Plaquenil therapy. Testing included a comprehensive eye exam that consisted of an assessment of the posterior segment with careful evaluation of associated macular changes or signs of retinal disease. 4 Baseline fundus. Reused, with permission, from American Academy of Ophthalmology. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy, Revised 2016. The Ophthalmic News and Education Network, American Academy of Ophthalmology. This article is from June 2011 and may contain outdated material. Download PDF. Many systemic medications may cause retinal toxicity. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative.